Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News
Financial Results · Q3 2026

Stemtech Q3 2026 Results: Net Loss of $479K, Loss Narrows

Stemtech Corp reported a significant decline in net sales to $1.37 million for the nine months ended September 30, 2026, compared to $2.42 million in the prior year period. The company continues to operate at a loss, with a net loss of $1.93 million for the first nine months of 2026 and a total stockholders' deficit of $8.38 million.

Q3 2026 at a glance · $ million
MetricQ3 2026Q3 2025
Revenue0.30.9
Gross profit0.20.7
Profit before tax-0.5-0.8
Net income-0.5-0.8
EPS (diluted, $ a share)$-0.00$-0.01

A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.

Growth and margins
Revenue, year on year-66.9%
Gross margin75.6%
Operating margin-131.5%
Source

10-Q filed with the SEC, OTC: STEK. Figures from the filing's XBRL data; summary written with AI assistance from the filing.

Read the filing ↗

Stemtech Corp: key numbers

Share price
$0.0001Close, Nov 13
Market cap
$300K
Shares outstanding
3BLatest SEC cover page
Sector
Trade & Services
Industry
Wholesale-Drugs, Proprietaries & Druggists' SundriesSIC 5122

Today's reference numbers, updated daily. Not a valuation or a recommendation.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.